XZP-5809-TT1 Tablets in Patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer

NCT04622072 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

21

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic considerations

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: XZP-5809-TT1 Tablet

Sponsor

Sihuan Pharmaceutical Holdings Group Ltd.